Serdar DurdaGi

InstitutionBahcesehir University
AddressIstanbul
Turkey
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 1 publications in June 2020 and May 2021 and June 2021 and August 2021
    All Publications
    Bar chart showing 104 publications over 16 distinct years, with a maximum of 18 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Durdagi S, Dag Ç, Dogan B, Yigin M, Avsar T, Buyukdag C, Erol I, Ertem FB, Calis S, Yildirim G, Orhan MD, Guven O, Aksoydan B, Destan E, Sahin K, Besler SO, Oktay L, Shafiei A, Tolu I, Ayan E, Yuksel B, Peksen AB, Gocenler O, Yucel AD, Can O, Ozabrahamyan S, Olkan A, Erdemoglu E, Aksit F, Tanisali G, Yefanov OM, Barty A, Tolstikova A, Ketawala GK, Botha S, Dao EH, Hayes B, Liang M, Seaberg MH, Hunter MS, Batyuk A, Mariani V, Su Z, Poitevin F, Yoon CH, Kupitz C, Sierra RG, Snell EH, DeMirci H. Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing. Structure. 2021 12 02; 29(12):1382-1396.e6. PMID: 34403647.
      Citations: 1     Fields:    Translation:Cells
    2. Kanan T, Kanan D, Al Shardoub EJ, Durdagi S. Transcription factor NF-?B as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model. J Mol Graph Model. 2021 11; 108:107968. PMID: 34311260.
      Citations: 1     Fields:    Translation:Humans
    3. Akbayrak IY, Caglayan SI, Durdagi S, Kurgan L, Uversky VN, Ulver B, Dervisoglu H, Haklidir M, Hasekioglu O, Coskuner-Weber O. Structures of MERS-CoV macro domain in aqueous solution with dynamics: Impacts of parallel tempering simulation techniques and CHARMM36m and AMBER99SB force field parameters. Proteins. 2021 10; 89(10):1289-1299. PMID: 34008220.
      Citations:    Fields:    Translation:HumansCells
    4. DurdaGi S. Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target. Turk J Biol. 2020; 44(3):185-191. PMID: 32595355.
      Citations: 7